Younger, Stronger, Smarter: The Future of Gene Therapy with Liz Parrish of BioViva

"BioViva is engaging in a bold implementation of genetic rejuvenation therapies - a first step on a path that I have been proposing for 15 years"

-Aubrey de Grey

"Elizabeth Parrish has taken the bull by the horns to spearhead an approach to cure aging using gene therapy that no one has ever had the guts to do before. Her gene therapy approach at BioViva makes all of the previous theoretical iterations of telomerase activation nearly obsolete. It will finally deliver on the promise of my team’s discovery of the hTR and hTERT genes at Geron Corporation and take that promise to the next, powerful and groundbreaking level. THIS is the future of Telomere Biology and therefore human longevity."

-Bill Andrews

Elizabeth Parrish is the Director of Outreach at the Complex Biological Systems Alliance (CBSA), Founder at BioTrove Investments, Secretary of the Board at the Regenerative Technology Alliance, and Admin Management at 3 Circles LLC. 
 
Liz is a leading voice of progress, reason, and education for the advancement of biotechnology and serves as a Motivational Speaker for the Life Sciences. She is actively involved in international educational media outreach and works with the International Longevity Alliance (ILA).
 
The Complex Biological Systems Alliance (CBSA) is an international multidisciplinary team of researchers investigating fundamental questions in biology and medicine. The CBSA is a unique platform for advanced scientific discourse and discovery. The mission of the CBSA is to further scientific understanding of biological complexity and the nature and origins of human disease.
 
To this end, the CBSA is developing novel mathematical, statistical, and experimental models to uncover fundamental threads of molecular information essential to key cellular functions and biological processes. CBSA members are afforded access to these tools to expedite scientific publication of their research. Moreover, these models provide the means to establish a new paradigm in evolutionary biology.

BioTrove Investments is committed to offering a meaningful way for people to fund research in biotech. This research will help alleviate disease caused by cellular degeneration. New evidence supports the important role of genetics, stem cells, and biotech on health, longevity, and curing of disease. BioTrove Investments wishes to advance research throughout the world to accomplish cures and improve resistance to defects and disease, as well as to achieve physical improvements in the human body. They intend to create a voice for progress, reason, and education for the advancement of biotech.
 
The Regenerative Technology Alliance (RTA) is a 501(c)(6) nonprofit trade association that brings together individuals, companies, and organizations who work in advancing the emerging field cell & regenerative medicine. 
 
The mission of the RTA is to be a strong and unifying voice in the emerging field of regenerative technologies; to bring together the leaders of this field to develop true global standards for the processing of human tissues & cells used in the field of regenerative medicine; to provide leadership to effectively self-manage & self-police the industry; and to actively engage with regulators & health agencies to develop a third way model for the safe translations of cell therapies from the bench to the bedside.